DIN 02519968 — PEMAZYRE 13.5 MG
PEMAZYRE is a tablet of Pemigatinib marketed by INCYTE CORPORATION. The full Pemigatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02519968
- Brand name
- PEMAZYRE
- Active ingredient
- Pemigatinib
- Strength
- 13.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- INCYTE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Fibroblast growth factor receptor (FGFR) kinase inhibitor (targeted anticancer drug)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Pemigatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02519933 | PEMAZYRE | 4.5 MG | TABLET | INCYTE CORPORATION | MARKETED |
| 02519941 | PEMAZYRE | 9 MG | TABLET | INCYTE CORPORATION | MARKETED |